Drug intelligence / Profile preview

enclose tl matrix

Development stage: Preclinical
Administration: Topical

Overview

**Enclose TL Matrix** is a bioengineered skin and soft tissue substitute regulated as a human cell, tissue, and cellular and tissue-based product (HCT/P). It is designed for wound care, specifically for use as a skin substitute, and is provided per square centimeter for application to wounds. The product is classified under skin substitutes and biologicals in the Healthcare Common Procedure Coding System (HCPCS). It is typically used in clinical settings for the treatment of acute or chronic wounds, such as diabetic ulcers, venous ulcers, or surgical wounds. The mechanism of action involves providing a scaffold or matrix that supports cell infiltration and tissue regeneration, facilitating the natural healing process.

Brand names: enclose tl matrix
Other names: enclose tl matrix

Beyond the preview

Go deeper on enclose tl matrix.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on enclose tl matrix.

Explore the full profile